Implantable Provider Group (IPG) Company Profile

12:03 EDT 25th June 2018 | BioPortfolio

News Articles [737 Associated News Articles listed on BioPortfolio]

Group Warns Implantable Cardiac Devices Are Vulnerable to Hacks

The American College of Cardiology's Electrophysiology Council highlights some of the cybersecurity concerns associated with pacemakers and implantable cardioverter-defibrillators. To date, there have...

Predictive Technology Group to Acquire FlagshipHealth Group

Predictive Technology Group, Inc., a provider of data analytics for disease identification and subsequent therapeutic intervention through unique biotechnology treatments has finalized an arrangement ...

North America Implantable Cardiac Monitors Market Report 2018

The North America Implantable Cardiac Monitors Market is expected to witness market growth of 6.8% CAGR during the forecast period 2017-2023 The implantable cardiac monitor, Read more...

Clanwilliam Group acquires NHS tech provider Informatica Systems in global expansion

An NHS technology provider that helps GPs to predict when specific patients are at risk of developing chronic diseases, and that allows planners to track... The post Clanwilliam Group acquires NHS tec...

First implantable glucose monitor approved by FDA

The first continuous glucose monitoring system with a fully implantable sensor has been approved by the US Food and Drug Administration.

Implantable Defibrillators in Patients with Chronic Kidney Disease: Think Twice

In patients with CKD, heart failure, and low ejection fraction, implantable cardioverter-defibrillators did not improve survival but were associated with increased risk for complications.

MRIs proven safe for patients with FDA-unapproved implantable devices

Longtime claims that heart patients fitted with

CMS to change reimbursement for MRI of implantable devices

CMS announced a change in its payment policy to make it easier for patie

Drugs and Medications [167 Associated Drugs and Medications listed on BioPortfolio]

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Novo Nordisk]

NOVOLIN N Human Insulin Isophane Suspension (recombinant DNA origin) 100 units/mL

Androgel [Abbott Products, Inc.]

These highlights do not include all the information needed to use ANDROGEL 1.62% safely and effectively. See full prescribing information for ANDROGEL 1.62%.AndroGel (testosterone gel) 1.62% for topic...

Ciprofloxacin [NorthStar Rx LLC]

Ciprofloxacin Tablets, USP

Lamotrigine [American Health Packaging]

LAMOTRIGINE TABLETS (Chewable, Dispersible)

PubMed Articles [2267 Associated PubMed Articles listed on BioPortfolio]

Exploring the patients' experiences of living with a subcutaneous implantable cardioverter defibrillator.

The implantable cardioverter defibrillator provides effective treatment for the prevention of sudden cardiac arrest but significant risks associated with transvenous implantation persist. The subcutan...

Promoting Secure Provider-to-Provider Communication With Electronic Health Record Messaging: An Educational Outreach Study.

With increasing electronic health record (EHR) use, providers are talking less with one another. Now, many rely on EHRs, informal emails, or texts, introducing fragmentation and new data security chal...

Sterilization of Implantable Polymer-Based Medical Devices: A Review.

This review article is focused on the sterilization techniques used for polymer-based implantable medical devices as well as the regulatory aspects governing sterile medical devices. Polymeric materia...

The Provider's Body in the Therapeutic Relationship: How Complementary and Alternative Medicine Providers Describe Their Work as Healers.

Although the body is central to health outcomes, the provider's body has been largely absent in the provider-patient relationship. Drawing upon semi-structured interviews with complementary and altern...

In Response to "Care Provider or Service Provider: What Should the Role of Radiation Oncologists Be in the Future?"

Clinical Trials [4528 Associated Clinical Trials listed on BioPortfolio]

Assessment of Appropriate Implantable Cardioverter Defibrillator (ICD) Implantation for Primary Prevention of Sudden Cardiac Death

Prophylactic implant of an ICD (implantable cardioverter defibrillator) for prevention of sudden cardiac death from a life-threatening heart rhythm abnormality is a standard recommendatio...

Multi-centre Observational Registry on Patients With Implantable Devices Remotely Monitored

Multicentric, observational, retrospective registry including patients underwent implantable device implantation (pacemaker or ICD) for any indication in the period from 2009 to 2016, foll...

Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics

The purpose of the study is to determine the comparative effectiveness of a provider-only intervention and a parent plus provider intervention to increase initiation of HPV vaccination amo...

Electronic Patient Notification of Remote ICD Data: Impact of Patient Engagement on Outcomes in the Merlin.Net™

Remote monitoring of implantable cardioverter-defibrillators (ICDs) for patients has led to efficient, safe, and satisfying analysis of their device and cardiac status; resulting in an ove...

Further Acute Research of a Subcutaneous Implantable Defibrillator (S-ICD) System

The purpose is to further evaluate the operation, safety, and feasibility of a subcutaneous implantable defibrillator (S-ICD) system in patients who require an implantable cardioverter def...

Companies [2265 Associated Companies listed on BioPortfolio]

Implantable Provider Group

Implantable Provider Group streamlines the management and delivery of implantable medical devices by working directly with commercial insurance payors, clinical providers and faci...

Implantable Provider Group (IPG)

Access MediQuip, LLC

Access MediQuip was founded in 1997 and is the nation's first and largest provider of outsourced implantable medical device management solutions. The company works with thousands of payers, manufactur...

TYRX®, Inc.

TYRX, Inc. commercializes innovative, implantable combination drug+device products focused on infection control, including the AIGISRx® Antibacterial Envelope, designed to redu...

Secant Group

Secant Group engineers medical textiles and biomedical structures that enable repair, recovery, and regeneration of the human body. Using advanced polymers, metals and composites,...

More Information about "Implantable Provider Group (IPG)" on BioPortfolio

We have published hundreds of Implantable Provider Group (IPG) news stories on BioPortfolio along with dozens of Implantable Provider Group (IPG) Clinical Trials and PubMed Articles about Implantable Provider Group (IPG) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Implantable Provider Group (IPG) Companies in our database. You can also find out about relevant Implantable Provider Group (IPG) Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record